​

Funding Round

Post-IPO Debt - ASLAN Pharmaceuticals

Post-IPO Debt - ASLAN Pharmaceuticals

Investment Firm

Overview

ASLAN Pharmaceuticals is an oncology-focused biotechnology company developing a portfolio of immuno-oncology agents and targeted therapies.

Announced Date

Jul 13, 2021

Funding Type

Post Ipo Debt

Highlights

Location

Asia

Social

Investor Lead

K2 HealthVentures

K2 HealthVentures

K2 HealthVentures is a debt and early_stage_venture and late_stage_venture and post_ipo and private_equity firm.

Participant Investors

2

Investor Name
Participant InvestorK2 HealthVentures
Participant InvestorArmentum Partners

Round Details and Background

ASLAN Pharmaceuticals raised $45000000 on 2021-07-13 in Post-IPO Debt

ASLAN Pharmaceuticals is an oncology-focused biotechnology company developing a portfolio of immuno-oncology agents and targeted therapies.

Company Funding History

10

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jan 07, 2016
Series C - ASLAN Pharmaceuticals
-9.0M
Dec 07, 2015
Series C - ASLAN Pharmaceuticals
6-34.0M
Oct 10, 2013
Series B - ASLAN Pharmaceuticals
4-22.0M
Jul 20, 2011
Series A - ASLAN Pharmaceuticals
1-12.0M

Recent Activity

There is no recent news or activity for this profile.